Chromosomal Sensitivity to Ionising Radiation in Lymphocytes of Patients with Head and Neck cancer
-
Farshid Farhan
,
Majid Mahmoodi
,
Cyrus Azimi
,
Mohammad-Ali Mohagheghi
,
Farideh Farzanfar
,
Azam Noormohammadi
,
Malihea Khaleghian
,
Mahbod Esfahani
,
Abbas Jafari
,
Zahra Safari
,
Kouros Divsalar
Abstract
Background: The aim of this study was to test the in vitro sensitivity of lymphocytes of patients with head and neck cancer against gamma irradiation and also to find out if the frequencies of chromosomal aberrations correlate with side effects of radiotherapy.Methods: Peripheral blood of 101 patients with head and neck cancer was collected before the onset of radiotherapy, cultured and irradiated in the G-2 or the G-0 phase of the cell cycle. Lymphocytes of 40 healthy donors were treated in the same way. Chromosomal aberrations such as chromosome and chromatid breakages, chromosome and chromatid gaps, chromatid exchanges and micronuclei were scored in metaphase cells of the patient and control groups.Results: The frequency of radiation- induced G2 aberrations in lymphocytes of patients were on average higher than that of healthy donors (P=0.001 for chromosomal breaks). The frequency of radiation-induced micronuclei in the G0 assay were also higher in patients than that in controls (P=0.05). The results also indicate that there is no correlation between the two assays. No significant correlation was observed between aberration frequencies in lymphocytes and the degree of both early and late normal tissue reactions.Conclusion: The induced chromosomal aberration frequencies in lymphocytes of patients with head and neck cancer are higher than those in healthy individuals, however, it does not appear to have a predictive value for the risk of developing side effects to radiotherapyArgiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008;371(9625):1695e1709.
Duvvuri U, Myers JN. Cancer of the head and neck is the sixth most common cancer worldwide. Curr Probl Surg 2009;46(2): 114e117.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. 2010;127(12):2893-917.
Agrawal N, Ha PK. Management of early-stage laryngeal cancer. Otolaryngol Clin North Am 2008;41(4):757e769.
Cooper JS, Porter K, Mallin K, et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009;31(6):748e758.
Pelucchi C, Gallus S, Garavello W, Bosetti C, La Vecchia C. Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 2008; 17(4):340-4.
Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009;18(2):541-550.
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Journal of the National Cancer Institute. 2007;99(10):777-89.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papilloma virus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26(4):612-619.
Dahlstrand H, Na¨sman A, Romanitan M, Lindquist D, Ramqvist T, Dalianis T. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008;28(2B):1133-38.
Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006; 12: 701–09.
Perez-Ordonez B, Beauchemin M, Jordan RC. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006; 59: 445–53.
Suárez C, Rodrigo JP, Ferlito A, Cabanillas R, Shaha AR, Rinaldo A. Tumours of familial origin in the head and neck. Oral oncology. 2006;42(10):965-78.
Garavello W, Foschi R, Talamini R, La Vecchia C, Rossi M, Dal Maso L, et al. Family history and the risk of oral and pharyngeal cancer. International journal of cancer. 2008;122(8):1827-31.
Ozar MK, Orta T. The use of chromosome aberrations in predicting breast cancer risk. JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2005;24(2):217.
Baria K, Warren C, Roberts SA, West C, Scott D. Chromosomal radiosensitivity as a marker of predisposition to common cancers? British Journal of Cancer. 2001;84(7):892.
Zhu Y, Spitz MR, Zheng YL, Hong WK, Wu X. BPDE‐induced lymphocytic 3p21. 3 aberrations may predict head and neck carcinoma risk. Cancer. 2002;95(3):563-8.
Varga D, Hoegel J, Maier C, Jainta S, Hoehne M, Patino-Garcia B, et al. On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis. 2006;21(5):313-20.
Gatti RA (2001) The inherited basis of human radiosensitivity. Acta Oncol 40: 702–711
Tauchi H, Matsuura S, Kobayashi J, et al. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 2002;21:8967–80.
Terzoudi GI, Manola KN, Pantelias GE, Iliakis G (2005) Checkpoint abrogation in G2 compromises repair of chromosomal breaks in ataxia telangiectasia cells. Cancer Res 65: 11292– 11296.
Lisowska H, Lankoff A, Wieczorek A, Florek A, Kuszewski T, Góźdź S, et al. Enhanced chromosomal radiosensitivity in peripheral blood lymphocytes of larynx cancer patients. International Journal of Radiation Oncology* Biology* Physics. 2006;66(4):1245-52.
Xiong P, Hu Z, Li C, Wang LE, El‐Naggar AK, Sturgis EM, et al. In vitro benzo [a] pyrene diol epoxide‐induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck. International Journal of Cancer. 2007;121(12):2735-40.
Székely G, Remenár É, Kásler M, Gundy S. Mutagen sensitivity of patients with cancer at different sites of the head and neck. Mutagenesis. 2005;20(5):381-5.
Braakhuis BJ, Nieuwint AW, Oostra AB, Joenje H, Flach GB, Graveland AP, Brakenhoff RH, Leemans CR. Sensitivity to chromosomal breakage as risk factor in young adults with oral squamous cell carcinoma. J Oral Pathol Med. 2015. doi: 10.1111/jop.12349. [Epub ahead of print].
Distel LV, Neubauer S, Keller U, Sprung CN, Sauer R, Grabenbauer GG. Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients. Radiotherapy and oncology. 2006;81(3):257-63.
Scott D, Barber JB, Spreadborough AR, Burrill W, Roberts SA (1999) Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays International journal of radiation biology 75:1-10
Scott D, Barber JB, Levine EL, Burrill W, Roberts SA (1998) Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? British journal of cancer 77:614-620
Papworth R, Slevin N, Roberts SA, Scott D. Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients. Br J Cancer. 2001;84(6):776-82.
Burgaz S, Coskun E, Demircigil GC, Kocabas NA, Cetindag F, Sunter O, Edinsel H. Micronucleus frequencies in lymphocytes and buccal epithelial cells from patients having head and neck cancer and their first-degree relatives.
Mutagenesis. 2011;26(2):351-6.
Terzoudi GI, Jung T, Hain J, Vrouvas J, Margaritis K, Donta-Bakoyianni C, Makropoulos V, Angelakis P, Pantelias GE. Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved. Int J Radiat Biol. 2000;76(5):607-15.
Gajecka M, Jarmuzs M, Szyfter W, Szyfter K. Non-random distribution of chromatid breaks in lymphocytes of laryngeal squamous cell carcinoma patients. Oncol Rep. 2004;12(1):153-7.
| Files | ||
| Issue | Vol 7 No 4 (2015) | |
| Section | Original Articles | |
| Keywords | ||
| Head and neck cancer gamma irradiation G2 assay micronuclei assay. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
